15 years later, is the FDA's produce safety overhaul working?
Fifteen years ago, the FDA overhauled its safety rules for fruits and vegetables, hoping to prevent outbreaks of foodborne illness. How's that system working today?
Read full article →Healthcare Policy
Latest Healthcare Policy news from across the web.
FDA advisory panel narrowly rejects compounding of one peptide, back another
Robert F. Kennedy Jr. has lauded peptides and said he takes them himself.
Read full article →There are already more U.S. measles cases this year than in all of 2025
The number of measles cases in the U.S. has surpassed the record-breaking tally for all of 2025, with five more months of 2026 still to come.
Read full article →STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions, and hires, here are the latest comings and goings in the pharma industry.
Read full article →STAT+: Fatal gene-editing trial in China raises ethics and oversight questions
Sanofi insulin pen in short supply, a win for peptide compounds, and more biotech news from The Readout
Read full article →STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more
In a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the drugs
Read full article →A new, separate outbreak of the diarrhea-causing parasite
A win for peptide proponents, autism advisory committees clash, and more health news from Morning Rounds
Read full article →STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started quickly.
Read full article →STAT+: White House offers its science blueprint: More AI, less life sciences
The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of research dollars from universities to industry.
Read full article →Senate advances MAHA-friendly bill for food warning labels and junk food ad bans
Unexpected alliances among Republicans and Democrats were on display over a bill meant to rein in ultra-processed foods.
Read full article →Opinion: The U.S. pharmaceutical supply chain problem is not about China
The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes Pooja Yerramilli.
Read full article →Opinion: I may be one of the last middle-class medical students who could afford to become a doctor
A federal loan program made it possible for Gauri Gurumurthy to pursue medicine. Now that program is changing.
Read full article →